Literature DB >> 21615384

Nurse-like cells show deregulated expression of genes involved in immunocompetence.

Nupur Bhattacharya1, Susanne Diener, Irina S Idler, Judith Rauen, Sarah Häbe, Hauke Busch, Annett Habermann, Thorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer, Daniel Mertens.   

Abstract

Chronic lymphocytic leukaemia (CLL) cells convert CD14(+) cells from patients into 'nurse-like' cells (NLCs). CLL cells can also convert CD14(+) peripheral blood mononuclear cells (PBMCs) from healthy donors into cells with morphological similarities to NLCs (CD14(CLL) -cells). However it is unclear whether only CLL cells induce this conversion process. This study showed that CD14(+) PBMCs from healthy donors could also be converted into differentiated cells (CD14(B) -cells) by non-malignant B-cells. In order to identify changes specifically induced by CLL cells, we compared gene expression profiles of NLCs, CD14(CLL) -cells and CD14(B) -cells. CD14(+) cells cultured with CLL cells were more similar to NLCs than those cultured with non-malignant B-cells. The most significant changes induced by CLL cells were deregulation of the antigen presentation pathway and of genes related to immunity. NLCs had reduced levels of lysozyme activity, CD74 and HLA-DR in-vitro while expression of inhibitory FCGR2B was increased. These findings suggest an impaired immunocompetence of NLCs which, if found in-vivo, could contribute to the immunodeficiency in CLL patients.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615384     DOI: 10.1111/j.1365-2141.2011.08747.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.

Authors:  Stefania Fiorcari; Silvia Martinelli; Jenny Bulgarelli; Valentina Audrito; Patrizia Zucchini; Elisabetta Colaci; Leonardo Potenza; Franco Narni; Mario Luppi; Silvia Deaglio; Roberto Marasca; Rossana Maffei
Journal:  Haematologica       Date:  2014-11-14       Impact factor: 9.941

2.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

3.  Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL.

Authors:  Deyan Yordanov Yosifov; Irina Idler; Nupur Bhattacharya; Michaela Reichenzeller; Viola Close; Daria Ezerina; Annika Scheffold; Billy Michael Chelliah Jebaraj; Sabrina Kugler; Johannes Bloehdorn; Jasmin Bahlo; Sandra Robrecht; Barbara Eichhorst; Kirsten Fischer; Anja Weigel; Hauke Busch; Peter Lichter; Hartmut Döhner; Tobias P Dick; Stephan Stilgenbauer; Daniel Mertens
Journal:  Leukemia       Date:  2019-07-12       Impact factor: 11.528

4.  Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.

Authors:  Giovanna Merchand-Reyes; Ramasamy Santhanam; Frank H Robledo-Avila; Christoph Weigel; Juan de Dios Ruiz-Rosado; Xiaokui Mo; Santiago Partida-Sánchez; Jennifer A Woyach; Christopher C Oakes; Susheela Tridandapani; Jonathan P Butchar
Journal:  J Immunol       Date:  2022-08-22       Impact factor: 5.426

5.  Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.

Authors:  Avery Polk; Ye Lu; Tianjiao Wang; Erlene Seymour; Nathanael G Bailey; Jack W Singer; Philip S Boonstra; Megan S Lim; Sami Malek; Ryan A Wilcox
Journal:  Clin Cancer Res       Date:  2016-06-22       Impact factor: 12.531

Review 6.  Targeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisib.

Authors:  Rossana Maffei; Stefania Fiorcari; Silvia Martinelli; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  J Hematol Oncol       Date:  2015-05-29       Impact factor: 17.388

Review 7.  Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk.

Authors:  Martijn Ha van Attekum; Eric Eldering; Arnon P Kater
Journal:  Haematologica       Date:  2017-08-03       Impact factor: 9.941

8.  Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.

Authors:  Loic Ysebaert; Mary Poupot; Frédéric Boissard; Marie Tosolini; Laetitia Ligat; Anne Quillet-Mary; Frederic Lopez; Jean-Jacques Fournié
Journal:  Oncotarget       Date:  2016-11-26

Review 9.  Using Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma.

Authors:  Tyler A Herek; Christine E Cutucache
Journal:  Front Oncol       Date:  2017-05-02       Impact factor: 6.244

10.  Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.

Authors:  Stefania Fiorcari; Rossana Maffei; Valentina Audrito; Silvia Martinelli; Elisa Ten Hacken; Patrizia Zucchini; Giulia Grisendi; Leonardo Potenza; Mario Luppi; Jan A Burger; Silvia Deaglio; Roberto Marasca
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.